Publication | Closed Access

Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis

InflammationSignal TransductionSignaling PathwayPancreatic CancerMedicineReceptor Tyrosine KinaseChronic InflammationCell DeathPathologyCerulein-induced PancreatitisC-jun N-terminal KinaseNew InhibitorCell BiologyCell Signaling